Ketamine Recruiting Phase 1 Trials for Depressive Disorder, Treatment-Resistant / Post Traumatic Stress Disorder (PTSD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02577250Ketamine Infusions for PTSD and Treatment-Resistant Depression